Vicarious Surgical Reports Drastic Cash Burn Reduction, Confirms NYSE Delisting and OTC Move

summarizeSummary

Vicarious Surgical announced Q4 and full-year 2025 financial results, highlighting a substantial reduction in operating expenses and a projected 58% decrease in 2026 cash burn, while confirming its decision not to appeal the NYSE delisting and its move to OTCID with an application for OTCQB.

check_boxKey Events

• Significant Cash Burn Reduction

  The company reported a full-year 2025 cash burn of $45.1 million, below its initial guidance of approximately $50 million. For 2026, Vicarious Surgical expects to further reduce its cash burn to approximately $19 million, representing a 58% decrease from 2025.

• Reduced Operating Expenses

  Total operating expenses decreased by 38% in Q4 2025 to $9.3 million (from $15.0 million in Q4 2024) and by 25% for the full year 2025 to $50.0 million (from $66.6 million in FY 2024), demonstrating aggressive cost control.

• NYSE Delisting Confirmed

  The company confirmed its decision not to appeal the NYSE's delisting determination, which was due to failing the $15 million market capitalization standard. Trading was immediately suspended on March 3, 2026.

• Transition to OTC Markets

  Vicarious Surgical's common stock commenced quotation on the OTCID market tier on March 4, 2026, under the symbol 'RBOT'. The company has also filed an application to upgrade its quotation to the OTCQB Venture Market.

auto_awesomeAnalysis

This filing provides critical updates for Vicarious Surgical, a company recently delisted from the NYSE. The most impactful news is the significant reduction in operating expenses and a projected 58% decrease in cash burn for 2026, from $45.1 million in 2025 to an estimated $19 million. For a nano-cap company with a cash balance of $9.8 million, this aggressive cost control is a vital step towards extending its operational runway and improving its chances of survival. While the confirmation of the NYSE delisting and the decision not to appeal are negative, these events were largely anticipated. The company's application to upgrade its quotation to the OTCQB Venture Market is a minor positive, indicating an effort to maintain some level of market visibility. Investors should monitor the company's ability to execute on its reduced cash burn guidance and its progress on the OTCQB application, as continued financial discipline is paramount for its future.